PEAK6 Investments’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2
Closed -$707 4430
2024
Q1
$691 Hold
2
﹤0.01% 3879
2023
Q4
$810 Hold
2
﹤0.01% 4075
2023
Q3
$834 Sell
2
-1
-33% -$387 ﹤0.01% 3946
2023
Q2
$1.11K Hold
3
﹤0.01% 3770
2023
Q1
$906 Buy
3
+1
+50% +$292 ﹤0.01% 4109
2022
Q4
$585 Sell
2
-1,561
-100% -$370K ﹤0.01% 4291
2022
Q3
$385K Buy
1,563
+1,560
+52,000% +$475K ﹤0.01% 3123
2022
Q2
$1.11K Sell
3
-10,258
-100% -$3.34M ﹤0.01% 3771
2022
Q1
$4.21M Sell
10,261
-151
-1% -$59.1K 0.01% 1226
2021
Q4
$4.88M Buy
10,412
+8,823
+555% +$3.8M 0.01% 1148
2021
Q3
$675K Buy
+1,589
New +$670K ﹤0.01% 2960
2021
Q2
Sell
-249
Closed -$82.3K 5860
2021
Q1
$70K Buy
+249
New +$71.3K ﹤0.01% 4410
2020
Q2
Sell
-2,771
Closed -$544K 4892
2020
Q1
$422K Buy
+2,771
New +$427K ﹤0.01% 2218
2019
Q4
Sell
-7,142
Closed -$1.01M 4167
2019
Q3
$1.01M Sell
7,142
-51,866
-88% -$7.14M 0.01% 1755
2019
Q2
$7.38M Buy
59,008
+15,712
+36% +$1.85M 0.05% 495
2019
Q1
$4.77M Buy
43,296
+40,749
+1,600% +$4.24M 0.03% 740
2018
Q4
$250K Buy
+2,547
New +$276K ﹤0.01% 2869

Other funds holding WST

PEAK6 Investments's WST Position: Q2 2024 in Review

PEAK6 Investments sold out of West Pharmaceutical (WST) in Q2 2024, closing a stake of 2 shares — an estimated $707 sold.

PEAK6 Investments first reported a position in WST in Q4 2018 and held it in 17 quarters. The position peaked at $7.38M in Q2 2019. 777 funds tracked by Wall St. Rank hold WST as of Q2 2024.

  • PEAK6 Investments reported no remaining West Pharmaceutical position as of Q2 2024 after selling out during the quarter.
  • PEAK6 Investments sold 2 West Pharmaceutical shares in Q2 2024, an estimated $707.
  • PEAK6 Investments first reported a position in West Pharmaceutical in Q4 2018 and held it in 17 quarters.
  • PEAK6 Investments's West Pharmaceutical position peaked at $7.38M in Q2 2019.
  • 777 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2024.

Based on PEAK6 Investments's 13F filing for Q2 2024, filed 14 Aug 2024.